Core Scientific, Inc./tx (CORZ)
Quote, stock score, analyst consensus, and SEC filings, plus insider and Congress trades when there are any.
NasdaqGS · Price as of · Nasdaq Real Time Price
- Profitability0/20
Losing money: $-1.43B net income over the last four reported quarters. Revenue over the last four reported quarters was $440.3M, up 27% from $348.0M the year before.
- Insider buying vs selling17/20
Some insider buying (3 buys, $342,332) against larger selling (17 sells, $2.3M). Any open-market buying is worth noticing. Separately, 5 new 5%+ stake disclosures (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings6/15
Share count up 5.2% in a year. Real dilution.
- Analysts21
- Implied upside+119.8%
- Target range$16.00 to $47.00
- EPS expected-$0.00
- A year ago-$0.20
- Revenue expected$193.2M +138%
- Estimate range-$0.05 to $0.06
- Priced move±12.3%
CORZ closed at $13.85 on Nov 3, down 16.6% since Oct 5. Chart read: price below both the 50-day and 200-day moving averages; the 50-day is below the 200-day (downtrend structure); trading at 8% of the 52-week range ($12.51 to $29.16).
Insider buying and selling at Core Scientific, Inc./tx (CORZ)
The most recent Form 4 on record for Core Scientific, Inc./tx (CORZ) is September 15, 2026, when Eric Stanton Weiss, Director, bought $97,980 of stock. An open-market purchase is money the filer chose to put in.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Eric Stanton Weiss · Director | Buy | $97,980 | September 15, 2026 | Notable buy |
| Elizabeth Crain · Director | Buy | $109,994 | August 20, 2026 | Notable buy |
| Eric Stanton Weiss · Director | Buy | $134,358 | August 18, 2026 | Notable buy |
| Todd M Duchene · See remarks | Sell | $200,974 | August 17, 2026 | Routine |
| Todd M Duchene · See remarks | Sell | $222,340 | August 3, 2026 | Routine |
| Todd M Duchene · See remarks | Sell | $209,476 | July 27, 2026 | Routine |
| Todd M Duchene · See remarks | Sell | $222,995 | July 20, 2026 | Routine |
Filed notices to sell
A Form 144 is filed beforean insider sells restricted stock. The Form 4 reporting the completed trade isn't due until two business days after the sale, so these land first. They are intentions, not transactions.
| Insider | Value | Filed | Status | Type |
|---|---|---|---|---|
| DUCHENE TODD M · Officer | $2.2M | October 13, 2026 | Not yet reported | Routine |
SEC filings
| Form | Filed | Description |
|---|---|---|
| SCHEDULE 13G | October 28, 2026 | View on EDGAR |
| 4 | October 28, 2026 | FORM 4 |
| 4 | October 20, 2026 | FORM 4 |
| 4 | October 20, 2026 | FORM 4 |
| 4 | October 14, 2026 | FORM 4 |
| 144 | October 13, 2026 | View on EDGAR |
| 4 | October 7, 2026 | FORM 4 |
| 4 | October 5, 2026 | FORM 4 |
Core Scientific news
All 23 articles
Core Scientific (CORZ) got conditional ERCOT approval for its Texas sites. The final power allocation is still open.
A three-paragraph 8-K puts numbers on the Texas grid question that has hung over Core Scientific since Governor Abbott ordered an audit of data centers in ERCOT's interconnection queue in August.
Leopold Aschenbrenner sold 11.5 million Core Scientific (CORZ) shares below the Aug. 3 low. The stock closed up 10%.
Leopold Aschenbrenner's Situational Awareness sold 11,519,078 Core Scientific (CORZ) shares in two block trades on Aug. 3 at an average near $19.59, both priced under the session low. The stake fell to 4.4% from 8.1%, which ends the reporting obligation. He still holds 14,089,395 shares.
Bitcoin is sliding, and the AI data center miners are sliding with it (IREN, CORZ, CLSK)
A dozen former bitcoin miners now call themselves AI data center companies. With bitcoin down near $58,300 and sliding a second day, most fell with it, while the names furthest from crypto held up best.
Articles that mention Core Scientific without it being the main subject.
CoreWeave (CRWV) and seven other AI infrastructure borrowers see bond spreads widen as a Goldman note says credit is ahead of stocks
We compared the same AI borrowers' bonds from Oct. 8 through Oct. 16, and every one widened while JNK barely moved. Now updated with what new debt would cost each borrower.
TeraWulf (WULF) gets Wall Street backing as shares fall 15% in a week
Morgan Stanley says TeraWulf is mispriced, while Cantor cut its target and still called the stock a generational buy.
JPMorgan double-upgrades IREN Ltd (IREN) as AI slowdown rattles peers
JPMorgan moved IREN two notches to overweight and lifted its target to $65 from $46, hours after co-CEO Daniel Roberts posted a long rebuttal to the calls for an AI slowdown. Every comparable name we checked fell on Monday. IREN did not.
Frequently asked questions
When does CORZ report earnings?
Core Scientific, Inc./tx (CORZ) is scheduled to report quarterly results on November 5, 2026, before the open. The 4-analyst consensus is -$0.00 per share on revenue of $193.2M for the quarter ended September 30, 2026, against -$0.20 and $81.1M a year earlier. The options market is pricing a move of about 12.3% in either direction on the report, based on the cost of the at-the-money straddle expiring November 6, 2026.
What do analysts expect for CORZ?
21 analysts cover Core Scientific, Inc./tx (CORZ). The consensus rating is Strong buy. The average price target is $30.62, in a range of $16.00 to $47.00.
Are insiders buying or selling CORZ?
We track Form 4 filings for Core Scientific, Inc./tx (CORZ). The activity listed on this page shows 3 open-market purchases and 4 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see CORZ SEC filings?
Recent filings are listed on this page, newest first. The latest is a SCHEDULE 13G filed October 28, 2026.